NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING

Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk of...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
Format: Article
Language:English
Published: Столичная издательская компания 2018-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1662
Tags: Add Tag
No Tags, Be the first to tag this record!